Premier: A clinical trial of comprehensive lifestyle modification for blood pressure control: Rationale, design and baseline characteristics

Annals of Epidemiology

Volumn 13, Issue 6, 2003, Pages 462-471

  Svetkey, Laura P ^a,f   Harsha, David W ^b   Vollmer, William M ^c   Stevens, Victor J ^c   Obarzanek, Eva ^d   Elmer, Patricia J ^c   Lin, Pao Hwa ^a   Champagne, Catherine ^b   Simons Morton, Denise G ^d   Aickin, Mikel ^c   Proschan, Michael A ^d   Appel, Lawrence J ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

Blood Pressure; Diet; Lifestyle; Weight Loss

Indexed keywords

GLUCOSE; HOMOCYSTEINE; INSULIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DIASTOLIC BLOOD PRESSURE; DIET; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0038160915     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(03)00006-1     Document Type: Article

References (40)

1. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 25:1995;305-313.
2. nd ed Hypertension: pathophysiology, diagnosis, and management. v. 1:1995;253-270 Raven Press, New York.
3. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias . Lancet. 335:1990;765-774.
4. Vasan R.S., Larson M.G., Leip E.P., Evans J.C., O'Donnell C.J., Kannel W.B., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 345:2001;1291-1297.
5. Stamler J., Stamler R., Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 153:1993;598-615.
6. Burt V.L., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examinations Surveys, 1960 to 1991. Hypertension. 26:1995;60-69.
7. Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch Intern Med. 153:1993;154-183.
8. Working Group on Primary Prevention of Hypertension. National High Blood Pressure Education Program: Working Group Report on Primary Prevention of Hypertension; 1993 (NIH Publication No. 93-2669).
9. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 336:1997;1117-1124.
10. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med. 157:1997;2413-2446.
11. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: The Trials of Hypertension Prevention, Phase II (TOHP-II). Arch Intern Med. 157:1997;657-667.
12. Whelton P.K., Appel L.J., Espeland M.A., Applegate W.B., Ettinger W.H., Kostis J.B., et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 279:1998;839-846.
13. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al. DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 344:2001;3-10.
14. Bandura A. Social Foundations of Thought and Action. A Social Cognitive Theory. 1986;Prentice Hall, Englewood Cliffs.
15. Watson D.L., Tharp R.G. Self-Directed Behavior: Self-Modification for Personal Adjustment. 5th Ed:1989;Brooks/Cole, Pacific Grove, California.
16. Prochaska J.O., DiClemente C.C. Stages and process of self-change in smoking: Towards an integrative model of change. J Consult Clin Psychol. 51:1983;390-395.
17. Marcus B.H., Banspach S.W., Lefebvre R.C., Rossi J.S., Carleton R.A., Abrams D.B. Using the stages of change model to increase the adoption of physical activity among community participants. Am J Health Promot. 6:1992;424-429.
18. Bandura A. Self-efficacy: The exercise of control. 1997;W. H. Freeman, New York.
19. Miller W.R., Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. 1991;The Guilford Press, New York.
20. Rollnick S., Miller W. What is motivational interviewing? Behavioral Cognitive Psychotherapy. 23:1995;325-334.
21. Rollnick S., Mason P., Butler C. Health Behavior Change: A Guide for Practitioners. 1999;Churchill Livingstone, New York.
22. Sacks F.M., Obarzanek E., Windhauser M.M., Svetkey L.P., Vollmer W.M., McCullough M., Karanja N., Lin P-H., Proschan M.A., Appel L.J., Bray G.A., Vogt T.M., Moore T.J., for the DASH investigators, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). Ann Epidemiol. 5:1995;108-118.
23. Wright B.M., Dore C.F. A random-zero sphygmomanometer. Lancet. 1:1970;337-338.
24. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment of older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 265:1991;3255-3264.
25. Satterfield S., Cutler J.A., Langford H.G., Applegate W.B., Borhani N.O., Brittain E., et al. Trials of Hypertension Prevention: Phase I design. Ann Epidemiol. 1:1991;455-471.
26. Svetkey L.P., Sacks F.M., Obarzanek E., Vollmer W.M., Appel L.J., Lin P-H., et al. The DASH diet, Sodium Intake and Blood Pressure Trial (DASH-Sodium): rationale and design. J Am Diet Assoc. 99:(Suppl):1999;S96-S104.
27. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 6:1979;65-70.
28. Aickin M., Gensler H. An improvement in the reporting of results while adjusting for multiple testing. Am J Public Health. 86:1996;726-728.
29. Proschan M.A. A multiple comparison procedure for three- and four-armed controlled trials. Stat Med. 18:1999;787-798.
30. The effects of nonpharmacologic interventions on blood pressure of persons with high-normal levels: Results of the Trials of Hypertension Prevention, Phase I (TOHP-I). JAMA. 267:1992;1213-1220.
31. Cook N.R., Cohen J., Hebert P.R., Taylor J.O., Hennekens C.H. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 155:1995;701-709.
32. Johnson C.L., Rifkind B.M., Sempos C.T., Carroll M.D., Bachorik P.S., Briefel R.R., et al. Declining serum total cholesterol levels among US adults. JAMA. 269:1993;3002-3008.
33. Obarzanek E., Sacks F.M., Vollmer W.M., Bray G.A., Miller E.R., Lin P.-H., et al. Effects of a blood pressure lowering diet on blood lipids: the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Clin Nutr. 74:2001;80-89.
34. Appel L.J., Miller E.R. III, Jee S.H., Stolzenberg-Solomon R., Lin P.-H., Erlinger T., et al. Effect of dietary pattern on serum homocysteine: results of a randomized, controlled feeding study. Circulation. 102:2000;852-857.
35. O'Brien E., Coats A., Owens P., Petrie J., Padfield P.L., Littler W.A., et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ. 320:2000;1128-1134.
36. Solberg L.I., Kottke T.E., Brekke M.L., Calomeni C.A., Conn S.A., Davidson G. Using continuous quality improvement to increase preventive services in clinical practice - going beyond guidelines. Prev Med. 25:1996;259-267.
37. Ammerman A., Caggiula A., Elmer P.J., Kris-Etherton P., Keyserling T., Lewis C., et al. Putting medical practice guidelines into practice: The cholesterol model. Am J Prev Med. 10:1994;209-216.
38. Budd M.A., Gruman J.C. Behavioral medicine: Taking its place in the mainstream of primary care. HMO Pract. 9:1995;51-52.
39. Zapka J.G., Merriam P., Ockene J. Smoking cessation benefits in HMOs. HMO Pract. 11:1997;27-33.
40. McAfee T., Wilson J., Dacey S., Sofian N., Curry S., Wagener B. Awaking the sleeping giant: Mainstreaming efforts to decrease tobacco use in an HMO. HMO Pract. 9:1995;138-143.